Retinoblastoma management during the COVID-19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries
Pediatr Blood Cancer
.
2021 Jan;68(1):e28584.
doi: 10.1002/pbc.28584.
Epub 2020 Aug 6.
Authors
Ido Didi Fabian
1
2
,
Andrew W Stacey
3
,
Richard Bowman
1
4
,
Vikas Khetan
5
,
Sharon Blum
2
,
Naama Keren-Froim
6
,
Sandra Staffieri
7
,
Allen Foster
1
;
Global Retinoblastoma Study Group
Affiliations
1
International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK.
2
Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel.
3
Department of Ophthalmology, University of Washington, Seattle, Washington.
4
Ophthalmology Department, Great Ormond Street Children's Hospital, London, UK.
5
Sankara Nethralaya, Chennai, India.
6
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
7
Department of Ophthalmology, Royal Children's Hospital, Parkville, Victoria, Australia.
PMID:
32762025
PMCID:
PMC7435529
DOI:
10.1002/pbc.28584
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Humans
Pandemics
Retinal Neoplasms*
Retinoblastoma*